PL428285A1 - Oral pharmaceutical composition containing tizanidine and method of its production - Google Patents

Oral pharmaceutical composition containing tizanidine and method of its production

Info

Publication number
PL428285A1
PL428285A1 PL428285A PL42828518A PL428285A1 PL 428285 A1 PL428285 A1 PL 428285A1 PL 428285 A PL428285 A PL 428285A PL 42828518 A PL42828518 A PL 42828518A PL 428285 A1 PL428285 A1 PL 428285A1
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
composition containing
oral pharmaceutical
tizanidine
production
Prior art date
Application number
PL428285A
Other languages
Polish (pl)
Other versions
PL245294B1 (en
Inventor
Stanisław HAN
Tomasz HAN
Karolina Kozar
Michał Zdun
Andrzej Smutkiewicz
Original Assignee
Centrum Badawczo-Rozwojowe Novasome Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centrum Badawczo-Rozwojowe Novasome Spółka Z Ograniczoną Odpowiedzialnością filed Critical Centrum Badawczo-Rozwojowe Novasome Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL428285A priority Critical patent/PL245294B1/en
Publication of PL428285A1 publication Critical patent/PL428285A1/en
Publication of PL245294B1 publication Critical patent/PL245294B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Przedmiotem zgłoszenia jest doustna kompozycja farmaceutyczna zawierająca niesteroidową substancję przeciwzapalną i tizanidynę zawiera ketoprofen lub jego sole w ilości od 1,25% wagowych do 80% wagowych w przeliczeniu na ketoprofen i tizanidynę lub jej sole w ilości od 0,1% wagowych do 20% wagowych w przeliczeniu na tizanidynę. Przedmiotem wynalazku jest także sposób wytwarzania tej kompozycji.The subject of the application is an oral pharmaceutical composition containing a non-steroidal anti-inflammatory substance and tizanidine, containing ketoprofen or its salts in an amount from 1.25% by weight to 80% by weight, based on ketoprofen, and tizanidine or its salts in an amount from 0.1% by weight to 20% by weight. expressed as tizanidine. The invention also relates to a method for the preparation of this composition.

PL428285A 2018-12-21 2018-12-21 Oral pharmaceutical composition containing ketoprofen and tizanidine and method of its preparation PL245294B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL428285A PL245294B1 (en) 2018-12-21 2018-12-21 Oral pharmaceutical composition containing ketoprofen and tizanidine and method of its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL428285A PL245294B1 (en) 2018-12-21 2018-12-21 Oral pharmaceutical composition containing ketoprofen and tizanidine and method of its preparation

Publications (2)

Publication Number Publication Date
PL428285A1 true PL428285A1 (en) 2020-06-29
PL245294B1 PL245294B1 (en) 2024-06-24

Family

ID=71124810

Family Applications (1)

Application Number Title Priority Date Filing Date
PL428285A PL245294B1 (en) 2018-12-21 2018-12-21 Oral pharmaceutical composition containing ketoprofen and tizanidine and method of its preparation

Country Status (1)

Country Link
PL (1) PL245294B1 (en)

Also Published As

Publication number Publication date
PL245294B1 (en) 2024-06-24

Similar Documents

Publication Publication Date Title
CL2020001048A1 (en) Monoclonal antibodies against bcma. (divisional request 201800281)
EA201691242A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AZD9291
MX2022005380A (en) COMPOSITIONS THAT INCLUDE CHOLINE.
EA201891267A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING EFFECTIVE URAT1 INHIBITOR
MX2021002382A (en) Salts and crystal forms of gabaa positive allosteric modulator.
JOP20180036A1 (en) Salts for new fruortin inhibitors
MX374628B (en) FORMULATION THAT INCLUDES A HYPOLIPIDEMIC AGENT.
MX2020012978A (en) Pharmaceutically acceptable salts of sepiapterin.
EA201700504A1 (en) 5-AROMATIC ALKINYL-SUBSTITUTED BENZOMIDE COMPOUND AND METHOD FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITION AND THEIR APPLICATION
EA202092829A1 (en) CONTROLLED RELEASE TOPACITINIB COMPOSITIONS
MX2020010300A (en) Mono-(acid) salts of 6-aminoisoquinolines and uses thereof.
AR100453A1 (en) COMPOSITIONS FOR ORAL CARE CONTAINING POLYETHYLENE GLYCOL FOR PHYSICAL STABILITY
MX393086B (en) TREATMENT FOR GINGIVITIS.
JOP20210072A1 (en) A new salt of a BCL-2 inhibitor, related crystalline form, method of preparation and pharmaceutical formulations containing it
CL2016003155A1 (en) Oral care compositions
BR112016013974A8 (en) compound, pharmaceutical composition and use of a compound.
MX2017007741A (en) Formulations of calcium and phosphate for oral inflammation.
EA201992844A1 (en) NEW ORAL COMPOSITIONS BASED ON BELINOSTAT
PL419047A1 (en) Composition that contains furazidin and method for producing it
EA202090397A1 (en) Fluoropiperidine Compounds as Pure 5-HT Receptor Antagonists
MX361002B (en) Anti-tatar oral care compositions providing crystallisation prevention.
EA202190009A1 (en) BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS IDH1 INHIBITORS
ZA202300107B (en) Pharmaceutically acceptable salts of sepiapterin
PL426472A1 (en) Medical use of domiphen bromide and a composition for treating inflammation in the oral cavity
PL412924A1 (en) Composition in the form of soft gelatin capsule, containing ketoprophene